Related Experiment Videos

A mouse model of familial hypertrophic cardiomyopathy

A A Geisterfer-Lowrance1, M Christe, D A Conner

  • 1Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA.

Science (New York, N.Y.)
|May 3, 1996
PubMed

Insights

A new mouse model mimics human familial hypertrophic cardiomyopathy (FHC). This model reveals cardiac dysfunction precedes pathology, with disease progression over time, offering insights into FHC natural history.

Area of Science:

  • Cardiovascular Research
  • Genetics
  • Animal Models

Background:

  • Familial hypertrophic cardiomyopathy (FHC) is a genetic heart disease.
  • Understanding FHC's natural history is crucial for developing effective treatments.

Purpose of the Study:

  • To create and characterize a novel mouse model of FHC.
  • To investigate the temporal relationship between cardiac dysfunction and histopathology in FHC.

Main Methods:

  • Introduction of an Arg 403 --> Gln mutation into the alpha cardiac myosin heavy chain (MHC) gene in mice.
  • Analysis of homozygous and heterozygous mice for survival, cardiac function, and histopathology.

Main Results:

  • Homozygous mice (alpha MHC 403/403) had perinatal lethality.
  • Heterozygous mice (alpha MHC 403/+) exhibited FHC-like cardiac pathology and dysfunction, with disease progression.
  • Cardiac dysfunction was observed before significant histopathological changes, and males showed more severe disease than females.

Conclusions:

  • The developed alpha MHC 403/+ mouse model accurately recapitulates key features of human FHC.
  • This model provides a valuable tool for studying FHC pathogenesis and evaluating therapeutic strategies.
  • Further research using this model can elucidate the long-term effects and exercise capacity limitations in FHC.

Related Concept Videos